AbCellera Biologics' Grant - II Round

AbCellera Biologics raised a round of funding on January 20, 2017. Investors include Bill & Melinda Gates Foundation.

AbCellera Biologics is a privately held company that provides technologies to biotechnology and pharmaceutical partners with the goal of discovery and development of next-generation monoclonal antibod…

Articles about AbCellera Biologics' Grant - II Round: